AR005986A1 - Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene - Google Patents

Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene

Info

Publication number
AR005986A1
AR005986A1 ARP970100745A ARP970100745A AR005986A1 AR 005986 A1 AR005986 A1 AR 005986A1 AR P970100745 A ARP970100745 A AR P970100745A AR P970100745 A ARP970100745 A AR P970100745A AR 005986 A1 AR005986 A1 AR 005986A1
Authority
AR
Argentina
Prior art keywords
derivatives
prepare
pharmaceutical composition
tetrahidropirimidin
thioxo
Prior art date
Application number
ARP970100745A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR005986A1 publication Critical patent/AR005986A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere a derivados de 2-tioxotetrahidropirimidin-4-ona para aumentar la concentración de colesterol de HDL, al uso de los mismos para prepararun medicamento y a una composición farmacéutica para tratar estados ateroescleróticos, tales como enfermedad cardíaca coronaria ydislipoproteinemias. Los compuestos están representados por la fórmula (I), donde R es alquilo C1-C6, alquenilo C2-C6; y R1, R2 y R3 sonindependientemente hidrógeno, halógeno o un alquilo inferior.
ARP970100745A 1996-03-07 1997-02-24 Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene AR005986A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1299396P 1996-03-07 1996-03-07

Publications (1)

Publication Number Publication Date
AR005986A1 true AR005986A1 (es) 1999-07-21

Family

ID=21757747

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100745A AR005986A1 (es) 1996-03-07 1997-02-24 Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene

Country Status (15)

Country Link
US (1) US5807864A (es)
EP (1) EP0885197A1 (es)
JP (1) JP2000507926A (es)
KR (1) KR19990087582A (es)
CN (1) CN1217715A (es)
AR (1) AR005986A1 (es)
AU (1) AU707732B2 (es)
BR (1) BR9708310A (es)
CA (1) CA2247933A1 (es)
HU (1) HUP9901968A3 (es)
IL (1) IL125974A0 (es)
NZ (1) NZ332199A (es)
TW (1) TW422840B (es)
WO (1) WO1997032855A1 (es)
ZA (1) ZA971911B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271728A1 (en) * 1996-11-14 1998-05-22 American Home Products Corporation Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents
US6562814B2 (en) 2000-10-02 2003-05-13 Wyeth 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
CN102423314A (zh) * 2011-11-26 2012-04-25 济南环肽医药科技有限公司 一种治疗免疫性肝损伤或免疫性肝纤维化的药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108858A (en) * 1979-02-14 1980-08-21 Kyowa Hakko Kogyo Co Ltd Novel dihydrouracil derivative and herbicide
JPS5939875A (ja) * 1982-08-31 1984-03-05 Sagami Chem Res Center ５−トリフルオロメチルジヒドロウラシル類の製造方法
JPS60243017A (ja) * 1984-05-16 1985-12-03 Kyowa Hakko Kogyo Co Ltd 抗けいれん組成物
JPH0651682B2 (ja) * 1986-09-05 1994-07-06 株式会社上野製薬応用研究所 ウラシル誘導体の製造方法
US4927451A (en) * 1988-12-30 1990-05-22 Uniroyal Chemical Company, Inc. 3-aryldihydrouracils
DE4318550A1 (de) * 1993-06-04 1994-12-08 Boehringer Mannheim Gmbh Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5554607A (en) * 1995-11-28 1996-09-10 American Home Products Corporation Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis

Also Published As

Publication number Publication date
CA2247933A1 (en) 1997-09-12
HUP9901968A3 (en) 2000-01-28
ZA971911B (en) 1998-09-07
JP2000507926A (ja) 2000-06-27
HUP9901968A2 (hu) 1999-10-28
KR19990087582A (ko) 1999-12-27
WO1997032855A1 (en) 1997-09-12
EP0885197A1 (en) 1998-12-23
NZ332199A (en) 1999-03-29
BR9708310A (pt) 1999-08-03
AU2123797A (en) 1997-09-22
TW422840B (en) 2001-02-21
IL125974A0 (en) 1999-04-11
AU707732B2 (en) 1999-07-15
CN1217715A (zh) 1999-05-26
US5807864A (en) 1998-09-15

Similar Documents

Publication Publication Date Title
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
AR034858A1 (es) Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
AR032471A1 (es) Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
CO4810373A1 (es) Compuestos azapoliciclicos condensados con arilo
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
BR9916282A (pt) Composto, uso de um um composto e método de tratamento
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
BR0010555A (pt) Inibidores de neuraminidases
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
ES2113127T3 (es) Derivado de androstenona.
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
PA8493701A1 (es) Compuestos para tratar la obesidad
ATE249213T1 (de) Pentafluorobenzensulfonamiden und analoge
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
ES2114931T3 (es) Nuevos esteres esteroidales.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
BR0012610A (pt) Novo derivado de difenilpiperidina
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
PA8534001A1 (es) Derivados de piperazina 1,4-disustituida utiles como bloqueadores alfa1,-adrenoceptores uro-selectivos
AR018347A1 (es) 1h-indazoles 1,5 y 3-o-sustituidos y sus sales fisiologicamente tolerables, utilizacion de los mismos para la preparacion de medicamentos, procedimientospara preparar dichos compuestos, las composiciones y preparaciones farmaceuticas que los contienen, y la utilizacion de dichos compuestos y prepara
AR005986A1 (es) Derivados de 2-thioxo-tetrahidropirimidin-4-ona, el uso de los mismos para preparar un medicamento y una composicion farmaceutica que los contiene